APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sialylated Human Milk Oligosaccharides (HMO)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sialylated Human Milk Oligosaccharides (HMO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026184 pages

Choose your research edition.

Industry ResearchSialylated Human Milk Oligosaccharides (HMO) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Sialylated Human Milk Oligosaccharides (HMO) Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Sialylated Human Milk Oligosaccharides (HMO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sialylated Human Milk Oligosaccharides (HMO) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Sialylated Human Milk Oligosaccharides (HMO) Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Sialylated Human Milk Oligosaccharides (HMO) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sialylated Human Milk Oligosaccharides (HMO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sialylated Human Milk Oligosaccharides (HMO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sialylated Human Milk Oligosaccharides (HMO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sialylated Human Milk Oligosaccharides (HMO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sialylated Human Milk Oligosaccharides (HMO) include Chr. Hansen (Jennewein Biotechnologie GmgH), DSM (Glycom A/S), Inbiose, Kyowa Hakko Bio, GeneChem Inc. and FrieslandCampina Ingredients, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sialylated Human Milk Oligosaccharides (HMO) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sialylated Human Milk Oligosaccharides (HMO) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sialylated Human Milk Oligosaccharides (HMO) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sialylated Human Milk Oligosaccharides (HMO) market size, projected growth trends, production technologies, key applications, and end-use industries.

Sialylated Human Milk Oligosaccharides (HMO) Segment by Company

Chr. Hansen (Jennewein Biotechnologie GmgH)

DSM (Glycom A/S)

Inbiose

Kyowa Hakko Bio

GeneChem Inc.

FrieslandCampina Ingredients

Sialylated Human Milk Oligosaccharides (HMO) Segment by Type

3'-Sialyllactose

6'-Sialyllactose

Sialylated Human Milk Oligosaccharides (HMO) Segment by Application

Infant Formula

Food

Others

Sialylated Human Milk Oligosaccharides (HMO) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sialylated Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sialylated Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sialylated Human Milk Oligosaccharides (HMO).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sialylated Human Milk Oligosaccharides (HMO) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sialylated Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sialylated Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sialylated Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sialylated Human Milk Oligosaccharides (HMO) Industry Trends Table 2. Sialylated Human Milk Oligosaccharides (HMO) Industry Drivers Table 3. Sialylated Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges Table 4. Sialylated Human Milk Oligosaccharides (HMO) Industry Restraints Table 5. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Manufacturers (t) & (2021-2026) Table 8. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers Table 9. Global Sialylated Human Milk Oligosaccharides (HMO) Average Sales Price (USD/t) of Manufacturers (2021-2026) Table 10. Global Sialylated Human Milk Oligosaccharides (HMO) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sialylated Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application Table 13. Global Sialylated Human Milk Oligosaccharides (HMO) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sialylated Human Milk Oligosaccharides (HMO) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 3'-Sialyllactose Table 17. Major Manufacturers of 6'-Sialyllactose Table 18. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type 2021 VS 2025 VS 2032 (t) Table 19. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (t) Table 20. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2027-2032) & (t) Table 21. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026) Table 22. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2027-2032) Table 23. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type 2021 VS 2025 VS 2032 (t) Table 24. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2026) & (t) Table 25. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2027-2032) & (t) Table 26. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2026) Table 27. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Infant Formula Table 29. Major Manufacturers of Food Table 30. Major Manufacturers of Others Table 31. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application 2021 VS 2025 VS 2032 (t) Table 32. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (t) Table 33. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2027-2032) & (t) Table 34. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2026) Table 35. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2027-2032) Table 36. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application 2021 VS 2025 VS 2032 (t) Table 37. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2026) & (t) Table 38. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2027-2032) & (t) Table 39. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2026) Table 40. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2027-2032) Table 41. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2021 VS 2025 VS 2032 (t) Table 42. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026) & (t) Table 43. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2021-2026) Table 44. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Forecasted by Region (2027-2032) & (t) Table 45. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 47. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (t) Table 48. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (t) Table 49. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 50. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (t) Table 51. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (t) Table 52. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 53. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (t) Table 54. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (t) Table 55. South America, Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 56. South America, Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (t) Table 57. South America, Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (t) Table 58. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2021-2026) Table 62. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2027-2032) Table 63. Chr. Hansen (Jennewein Biotechnologie GmgH) Company Information Table 64. Chr. Hansen (Jennewein Biotechnologie GmgH) Business Overview Table 65. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 67. Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Development Table 68. DSM (Glycom A/S) Company Information Table 69. DSM (Glycom A/S) Business Overview Table 70. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 72. DSM (Glycom A/S) Recent Development Table 73. Inbiose Company Information Table 74. Inbiose Business Overview Table 75. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 77. Inbiose Recent Development Table 78. Kyowa Hakko Bio Company Information Table 79. Kyowa Hakko Bio Business Overview Table 80. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 82. Kyowa Hakko Bio Recent Development Table 83. GeneChem Inc. Company Information Table 84. GeneChem Inc. Business Overview Table 85. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 87. GeneChem Inc. Recent Development Table 88. FrieslandCampina Ingredients Company Information Table 89. FrieslandCampina Ingredients Business Overview Table 90. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 92. FrieslandCampina Ingredients Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Sialylated Human Milk Oligosaccharides (HMO) Distributors List Table 96. Sialylated Human Milk Oligosaccharides (HMO) Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Sialylated Human Milk Oligosaccharides (HMO) Product Image Figure 2. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size (2021-2032) & (US$ Million) Figure 4. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (2021-2032) & (t) Figure 5. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price (USD/t) & (2021-2032) Figure 6. Global Top 5 and 10 Sialylated Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 3'-Sialyllactose Image Figure 9. 6'-Sialyllactose Image Figure 10. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021 VS 2025 VS 2032) & (t) Figure 11. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2032) Figure 13. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2032) Figure 16. Infant Formula Image Figure 17. Food Image Figure 18. Others Image Figure 19. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021 VS 2025 VS 2032) & (t) Figure 20. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2032) Figure 22. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2032) Figure 25. North America Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 26. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 27. U.S. Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 28. Canada Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 29. Mexico Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 30. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 31. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 32. Germany Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 33. France Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 34. U.K. Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 35. Italy Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 36. Netherlands Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 37. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 38. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 39. China Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 40. Japan Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 41. South Korea Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 42. Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 43. India Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 44. Australia Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 45. South America, Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 46. South America, Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2021-2032) Figure 47. Brazil Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 48. South Africa Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 49. Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 50. Turkey Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 51. Argentina Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 52. UAE Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 53. Egypt Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 54. Chile Sialylated Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2021-2032) & (t) Figure 55. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Figure 58. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Sialylated Human Milk Oligosaccharides (HMO) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Sialylated Human Milk Oligosaccharides (HMO) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 3'-Sialyllactose
  • 6'-Sialyllactose
Applications
  • Infant Formula
  • Food
  • Others
Companies covered
  • Chr. Hansen (Jennewein Biotechnologie GmgH)
  • DSM (Glycom A/S)
  • Inbiose
  • Kyowa Hakko Bio
  • GeneChem Inc.
  • FrieslandCampina Ingredients

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sialylated Human Milk Oligosaccharides (HMO) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sialylated Human Milk Oligosaccharides (HMO) Market Dynamics
  1. 2.1 Sialylated Human Milk Oligosaccharides (HMO) Industry Trends
  2. 2.2 Sialylated Human Milk Oligosaccharides (HMO) Industry Drivers
  3. 2.3 Sialylated Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
  4. 2.4 Sialylated Human Milk Oligosaccharides (HMO) Industry Restraints
3 Sialylated Human Milk Oligosaccharides (HMO) Market by Manufacturers
  1. 3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sialylated Human Milk Oligosaccharides (HMO) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sialylated Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application
  7. 3.7 Global Sialylated Human Milk Oligosaccharides (HMO) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sialylated Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sialylated Human Milk Oligosaccharides (HMO) Tier 1, Tier 2, and Tier 3
4 Sialylated Human Milk Oligosaccharides (HMO) Market by Type
  1. 4.1 Sialylated Human Milk Oligosaccharides (HMO) Type Introduction
  2. 4.1.1 3'-Sialyllactose
  3. 4.1.2 6'-Sialyllactose
  4. 4.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type
  5. 4.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2032)
  7. 4.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type
  9. 4.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2032)
  11. 4.3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2032)
5 Sialylated Human Milk Oligosaccharides (HMO) Market by Application
  1. 5.1 Sialylated Human Milk Oligosaccharides (HMO) Application Introduction
  2. 5.1.1 Infant Formula
  3. 5.1.2 Food
  4. 5.1.3 Others
  5. 5.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application
  6. 5.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2032)
  8. 5.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application
  10. 5.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2032)
  12. 5.3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2032)
6 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region
  1. 6.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2021-2032)
  3. 6.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026)
  4. 6.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sialylated Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region
  1. 7.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region
  2. 7.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2021-2026)
  4. 7.1.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2027-2032)
  5. 7.1.4 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032)
  8. 7.2.2 North America Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032)
  11. 7.3.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chr. Hansen (Jennewein Biotechnologie GmgH)
  2. 8.1.1 Chr. Hansen (Jennewein Biotechnologie GmgH) Company Information
  3. 8.1.2 Chr. Hansen (Jennewein Biotechnologie GmgH) Business Overview
  4. 8.1.3 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  6. 8.1.5 Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Developments
  7. 8.2 DSM (Glycom A/S)
  8. 8.2.1 DSM (Glycom A/S) Company Information
  9. 8.2.2 DSM (Glycom A/S) Business Overview
  10. 8.2.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  12. 8.2.5 DSM (Glycom A/S) Recent Developments
  13. 8.3 Inbiose
  14. 8.3.1 Inbiose Company Information
  15. 8.3.2 Inbiose Business Overview
  16. 8.3.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  18. 8.3.5 Inbiose Recent Developments
  19. 8.4 Kyowa Hakko Bio
  20. 8.4.1 Kyowa Hakko Bio Company Information
  21. 8.4.2 Kyowa Hakko Bio Business Overview
  22. 8.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  24. 8.4.5 Kyowa Hakko Bio Recent Developments
  25. 8.5 GeneChem Inc.
  26. 8.5.1 GeneChem Inc. Company Information
  27. 8.5.2 GeneChem Inc. Business Overview
  28. 8.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  30. 8.5.5 GeneChem Inc. Recent Developments
  31. 8.6 FrieslandCampina Ingredients
  32. 8.6.1 FrieslandCampina Ingredients Company Information
  33. 8.6.2 FrieslandCampina Ingredients Business Overview
  34. 8.6.3 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  36. 8.6.5 FrieslandCampina Ingredients Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sialylated Human Milk Oligosaccharides (HMO) Value Chain Analysis
  2. 9.1.1 Sialylated Human Milk Oligosaccharides (HMO) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sialylated Human Milk Oligosaccharides (HMO) Production Mode & Process
  6. 9.2 Sialylated Human Milk Oligosaccharides (HMO) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sialylated Human Milk Oligosaccharides (HMO) Distributors
  9. 9.2.3 Sialylated Human Milk Oligosaccharides (HMO) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst